Compare
Lindblad Expeditions Holdings, Inc. vs Verra Mobility Corp vs DocGo Inc. vs Strata Critical Medical, Inc.
| Latest fiscal year | Lindblad Expeditions Holdings, Inc. LIND | Verra Mobility Corp VRRM | DocGo Inc. DCGO | Strata Critical Medical, Inc. SRTA |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $771.02M | $979.08M | $322.20M | $197.14M |
| Revenue growth (YoY) | +19.6% | +11.4% | -47.7% | +34.3% |
| Gross margin | 45.8% (computed) | n/a | n/a | 20.9% |
| Operating margin | 5.9% | 24.4% | -55.3% | -11.3% |
| Net margin | -3.9% | 14.0% | -56.6% | 21.0% |
| Net income | -$29.72M | $136.63M | -$182.40M | $41.35M |
| EPS (Diluted) | -$0.63 | $0.85 | -$1.84 | $0.50 |
| Operating cash flow | $111.58M | $255.80M | $34.45M | -$48.91M |
| Free cash flow | $63.84M | $136.71M | $29.91M | -$58.51M |
| Cash & equivalents | $256.69M | $65.27M | $51.02M | $30.97M |
| Total assets | $979.96M | $1.65B | $217.10M | $325.47M |
| Total liabilities | $1.13B | $1.35B | $91.23M | $46.40M |
| Shareholders' equity | -$284.53M | $292.96M | $144.01M | $279.07M |
| Return on year-end equity | n/a | 46.6% | -126.7% | 14.8% |
| Shares outstanding | 55.32M | 153.56M | 98.64M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Lindblad Expeditions Holdings, Inc. | Verra Mobility Corp | DocGo Inc. | Strata Critical Medical, Inc. |
|---|---|---|---|---|
| Latest | $771.02M Ended 2025-12-31 | $979.08M Ended 2025-12-31 | $322.20M Ended 2025-12-31 | $197.14M Ended 2025-12-31 |
| 1 year earlier | $644.73M Ended 2024-12-31 | $879.21M Ended 2024-12-31 | $616.56M Ended 2024-12-31 | $146.82M Ended 2024-12-31 |
| 2 years earlier | $569.54M Ended 2023-12-31 | $817.31M Ended 2023-12-31 | $624.29M Ended 2023-12-31 | $225.18M Ended 2023-12-31 |
| 3 years earlier | $421.50M Ended 2022-12-31 | $741.60M Ended 2022-12-31 | $440.52M Ended 2022-12-31 | $146.12M Ended 2022-12-31 |
| 4 years earlier | $147.11M Ended 2021-12-31 | $550.59M Ended 2021-12-31 | $318.72M Ended 2021-12-31 | n/a |